glp 1 agonists for diabetes GLP-1 receptor individualized treatment of type 2 mellitus GLP-1 Receptor Agonists: A Game-Changer
Description
Exploratory analysis of eating- and physical activity-related outcomes from a randomized controlled trial for weight loss maintenance with exercise and liraglutide single or combination treatment
Novo is now up to $10 billionand Pfizer has matched it, the Financial Times reported Nov
[DOI] [PMC free article] [PubMed] [Google Scholar] 69.Allison DB, Gadde KM, Garvey WT, et al
[DOI] [PMC free article] [PubMed] [Google Scholar] 166.Jun L.S., Millican R.L., Hawkins E.D., Konkol D.L., Showalter A.D., Christe M.E
This method helps target multiple disease pathways at the same time
